References
- Monico CG, Olson JB, Milliner DS. Implications of geno-type and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria. Am J Nephrol 2005; 25: 183–8. Epub 2005 Apr 21.
- Detry O, Honore P, DeRoover A. Reversal of oxalosis car-diomyopathy after combined liver and kidney transplanta-tion. Transpl Int 2002; 15: 50-2. Epub 2002 Jan 18.
- Yoshioka J, Park YD, Tanaka Y, Kobayashi Y. Echocardio-graphic features in a patient with primary oxalosis. Echocar-diography 2001; 18: 599–602.
- Palka P, Duhig E, Carey L, Galbraith A. Primary oxalosis with cardiac involvement: echocardiographic features of an unusual form of cardiomyopathy. Circulation 2001; 103: E122–3.
- Riksen NP, Timmers HJ, Assmann KJ. Renal graft failure due to type 1 primary hyperoxaluria. Neth J Med 2002; 60 (10): 407–10.
- Schulze MR, Wachter R. Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II. Clin Res Car-diol 2006; 95 (4): 235-40. Epub 2006 Feb 17.
- Rodby RA, Tyszka TS, Williams SW. Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. Am J Med 1991; 90 (4): 498–504.
- Diaz C, Catalinas FG, de Alvaro F. Long daily hemodialy-sis sessions correct systemic complications of oxalosis prior to combined liver-kidney transplantation: case report. Ther Apher Dial 2004; 8 (1): 52–5.
- Jamieson NV; European PHI Transplantation Study Group. A 20-year experience of combined liver/kidney transplanta-tion for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004. Am J Nephrol 2005; 25 (3): 282-9. Epub 2005 Jun 15.